Stock Fundamentals

AI Research Report

Generate a comprehensive financial analysis report powered by AI

INGN.US Logo

INGN.US - Current Price

$6.21

Company Information

▼
Company Name
Inogen Inc
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
ISIN: US45780L1044
CIK: 0001294133
CUSIP: 45780L104
Currency: USD
Full Time Employees: 766
Phone: 805 562 0500
Website: https://www.inogen.com
Fiscal Year End: December
IPO Date: Feb 14, 2014
Description:

Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One and Inogen Rove, an ambulatory solutions for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

Address:

859 Ward Drive, Goleta, CA, United States, 93111

Directors & Officers

▼
Name Title Year Born
Mr. Kevin R. M. Smith President, CEO & Director 1971
Mr. Michael J. Bourque CPA Executive VP, CFO & Corporate Treasurer 1963
Mr. Kevin P. Smith General Counsel, Secretary & Executive VP of Business Development 1971
Mr. Grgoire Ramade Executive VP & Chief Commercial Officer 1970
Mr. Philip Corrin Senior Vice President of Operations & Supply Chain NA
Ms. Mary Wright Chief Accounting Officer 1986
Mr. Naga Rameswamy Chief Technology Officer NA
Ms. Lorna Williams Senior Vice President of Investor Relations NA
Ms. Jennifer Yi Boyer Executive VP of Enterprise Enablement & Chief Human Resources Officer 1974
Dr. Krishna Jhaveri Chief Medical Officer NA

Shares Statistics

▼
Shares Outstanding: 27.15M
Shares Float: 24.06M
% Insiders: 1,215.70%
% Institutions: 7,318.30%
Short % Float: 2.66%

Valuation Metrics

▼
Enterprise Value: $63.59M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

▼
Market Cap: $168.59M
EBITDA: $-9.75M
PEG Ratio: $3.48
Book Value: $7.26
Earnings/Share: $-1.00
Profit Margin: -7.31%
Operating Margin: -6.98%
ROA (TTM): -6.21%
ROE (TTM): -13.27%
Revenue (TTM): $347.03M
Revenue/Share (TTM): $13.47
Earnings Growth (YOY): 87.30%
Revenue Growth (YOY): 4.00%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

▼

Revenue & Net Income

Operating Expenses

Balance Sheet Overview

Earnings Per Share (EPS)

Earnings History

▼
Date EPS Actual EPS Estimate Difference Surprise %
Dec 31, 2025 0.00 -0.34 N/A 10,000.00%
Sep 30, 2025 -0.20 -0.21 N/A 476.19%
Jun 30, 2025 -0.15 -0.27 N/A 4,444.44%
Mar 31, 2025 -0.11 -0.25 N/A 5,600.00%
Dec 31, 2024 -0.24 -0.49 N/A 5,102.04%
Sep 30, 2024 -0.25 -0.49 N/A 4,897.96%
Jun 30, 2024 -0.24 -0.55 N/A 5,636.36%
Mar 31, 2024 -0.62 -0.76 N/A 1,842.11%
Dec 31, 2023 -1.14 -0.62 N/A -8,387.10%
Sep 30, 2023 -0.55 -0.49 N/A -1,224.49%
Jun 30, 2023 -0.42 -0.59 N/A 2,881.36%
Mar 31, 2023 -0.88 -0.81 N/A -864.20%
Dec 31, 2022 -0.20 -0.57 N/A 6,491.23%
Sep 30, 2022 -0.42 -0.42 N/A 0.00%
Jun 30, 2022 -0.15 -0.37 N/A 5,945.95%
Mar 31, 2022 -0.62 -0.51 N/A -2,156.86%
Dec 31, 2021 -1.01 -0.73 N/A -3,835.62%
Sep 30, 2021 0.53 -0.26 N/A 30,384.62%
Jun 30, 2021 0.22 -0.11 N/A 30,000.00%
Mar 31, 2021 -0.03 -0.27 N/A 8,888.89%
Dec 31, 2020 -0.23 -0.26 N/A 1,153.85%
Sep 30, 2020 -0.08 -0.02 N/A -30,000.00%
Jun 30, 2020 0.12 -0.08 N/A 25,000.00%
Mar 31, 2020 -0.07 -0.11 N/A 3,636.36%
Dec 31, 2019 -0.06 0.10 N/A -16,000.00%
Sep 30, 2019 0.31 0.23 N/A 3,478.26%
Jun 30, 2019 0.45 0.49 N/A -816.33%
Mar 31, 2019 0.24 0.30 N/A -2,000.00%
Dec 31, 2018 0.44 0.25 N/A 7,600.00%
Sep 30, 2018 0.73 0.52 N/A 4,038.46%
Jun 30, 2018 0.65 0.44 N/A 4,772.73%
Mar 31, 2018 0.48 0.29 N/A 6,551.72%
Dec 31, 2017 0.31 0.23 N/A 3,478.26%
Sep 30, 2017 0.33 0.29 N/A 1,379.31%
Jun 30, 2017 0.38 0.28 N/A 3,571.43%
Mar 31, 2017 0.27 0.14 N/A 9,285.71%
Dec 31, 2016 0.25 0.11 N/A 12,727.27%
Sep 30, 2016 0.16 0.13 N/A 2,307.69%
Jun 30, 2016 0.25 0.20 N/A 2,500.00%
Mar 31, 2016 0.11 0.12 N/A -833.33%
Dec 31, 2015 0.19 0.07 N/A 17,142.86%
Sep 30, 2015 0.13 0.13 N/A 0.00%
Jun 30, 2015 0.17 0.14 N/A 2,142.86%
Mar 31, 2015 0.06 0.03 N/A 10,000.00%
Dec 31, 2014 0.06 0.03 N/A 10,000.00%
Sep 30, 2014 0.11 0.06 N/A 8,333.33%
Jun 30, 2014 0.11 0.07 N/A 5,714.29%
Mar 31, 2014 0.05 0.04 N/A 2,500.00%
Dec 31, 2013 0.01 0.02 N/A -5,000.00%

Balance Sheet (Yearly)

▼
Date Cash Total Debt Total Assets Total Liabilities Total Equity
2024-12-31 $113.80M $N/A $296.19M $122.33M $173.86M
2023-12-31 $125.49M $N/A $326.19M $121.38M $204.81M
2022-12-31 $187.01M $N/A $405.04M $107.64M $297.41M
2021-12-31 $235.52M $N/A $489.51M $119.29M $370.23M
2020-12-31 $211.96M $N/A $461.85M $112.23M $349.62M
2019-12-31 $198.04M $N/A $447.34M $102.72M $344.62M
2018-12-31 $196.63M $N/A $375.90M $65.47M $310.42M
2017-12-31 $142.95M $N/A $275.07M $48.03M $227.04M
2016-12-31 $92.85M $N/A $214.05M $31.96M $182.09M
2015-12-31 $66.11M $N/A $161.31M $27.30M $134.02M
2014-12-31 $56.84M $N/A $140.09M $21.94M $118.15M
2013-12-31 $13.52M $N/A $82.40M $26.10M $56.30M
2012-12-31 $15.11M $N/A $47.59M $19.01M $28.58M
2011-12-31 $3.91M $N/A $24.13M $16.58M $7.56M

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
May 10, 2024 N/A N/A N/A N/A N/A N/A

Watchlist

0

No stocks in watchlist